Podium to Practice: ESMO® 2025 – BREAST: POSITIVE
OR
Explore more from your favourite experts – click their name to access their entire library of content.
Studies / Trials Discussed
LBA12 – 5-Year Follow-up Results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial
Studies/trials discussed:
LBA12 – 5-Year Follow-up Results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial
Login to view content
PLease Enter Your Email to view Content
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.